Oncology CAR-TCR 2023 – Jonathan Wofford In order for cell therapies to scale effectively, the industry is clamouring for standardisation around things like manufacturing and treatment administration.
News UK project addresses capacity issue in CGT manufacturing A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face